Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Nutrient intake and plasma β-amyloid.

Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N.

Neurology. 2012 Jun 5;78(23):1832-40. doi: 10.1212/WNL.0b013e318258f7c2. Epub 2012 May 2.

2.

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.

Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P, Pupi A, de Leon MJ, Mosconi L.

J Nutr Health Aging. 2015 Apr;19(4):413-23. doi: 10.1007/s12603-014-0534-0.

3.

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.

Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, Tsui WH, Li Y, Butler T, Osorio RS, Glodzik L, Vallabhajosula S, McHugh P, Marmar CR, de Leon MJ.

BMJ Open. 2014 Jun 24;4(6):e004850. doi: 10.1136/bmjopen-2014-004850.

4.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
5.

Ten-year change in plasma amyloid beta levels and late-life cognitive decline.

Okereke OI, Xia W, Selkoe DJ, Grodstein F.

Arch Neurol. 2009 Oct;66(10):1247-53. doi: 10.1001/archneurol.2009.207.

6.

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Seppälä TT, Herukka SK, Hänninen T, Tervo S, Hallikainen M, Soininen H, Pirttilä T.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1123-7. doi: 10.1136/jnnp.2010.205757. Epub 2010 May 16.

7.

Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.

Viswanathan A, Raj S, Greenberg SM, Stampfer M, Campbell S, Hyman BT, Irizarry MC.

Neurology. 2009 Jan 20;72(3):268-72. doi: 10.1212/01.wnl.0000339486.63862.db.

8.

Omega-3 fatty acids and risk of cognitive impairment and dementia.

Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ.

J Alzheimers Dis. 2003 Aug;5(4):315-22.

PMID:
14624027
9.

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole GM.

J Neurosci. 2005 Mar 23;25(12):3032-40.

10.

The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.

Liu CH, Bu XL, Wang J, Zhang T, Xiang Y, Shen LL, Wang QH, Deng B, Wang X, Zhu C, Yao XQ, Zhang M, Zhou HD, Wang YJ.

J Alzheimers Dis. 2016 Apr 8;52(3):1081-8. doi: 10.3233/JAD-151079.

PMID:
27079706
11.

Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.

Schupf N, Zigman WB, Tang MX, Pang D, Mayeux R, Mehta P, Silverman W.

Neurology. 2010 Nov 2;75(18):1639-44. doi: 10.1212/WNL.0b013e3181fb448b.

12.

A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.

Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.

Neuroscience. 2007 Oct 26;149(2):286-302. Epub 2007 Aug 14.

PMID:
17904756
13.

Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.

Devanand DP, Schupf N, Stern Y, Parsey R, Pelton GH, Mehta P, Mayeux R.

Neurology. 2011 Jul 12;77(2):125-31. doi: 10.1212/WNL.0b013e318224afb7. Epub 2011 Jun 29.

14.

Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women.

Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB.

J Nutr. 2004 Jul;134(7):1806-11.

15.

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up.

Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O.

J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1205-11. doi: 10.1093/gerona/gls107. Epub 2012 Apr 13.

PMID:
22503994
16.

Plasma ß-amyloid and cognitive decline.

Cosentino SA, Stern Y, Sokolov E, Scarmeas N, Manly JJ, Tang MX, Schupf N, Mayeux RP.

Arch Neurol. 2010 Dec;67(12):1485-90. doi: 10.1001/archneurol.2010.189. Epub 2010 Aug 9.

17.

Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Sun X, Chiu CC, Liebson E, Crivello NA, Wang L, Claunch J, Folstein M, Rosenberg I, Mwamburi DM, Peter I, Qiu WQ.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):238-44. doi: 10.1097/WAD.0b013e31819cb3ac.

18.

The demographic and medical correlates of plasma aβ40 and aβ42.

Metti AL, Cauley JA, Ayonayon HN, Harris TB, Rosano C, Williamson JD, Yaffe K; Health, Aging and Body Composition Study.

Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):244-9. doi: 10.1097/WAD.0b013e318260a8cb.

19.

Fatty acids as determinants of in-vivo lipid peroxidation: the EFFGE study in Eastern Finnish hypertensive and non-hypertensive subjects.

Kaikkonen JE, Vilppo T, Asikainen J, Voutilainen S, Kurl S, Salonen JT.

Ann Med. 2013 Sep;45(5-6):455-64. doi: 10.3109/07853890.2013.809915. Epub 2013 Jul 3.

PMID:
23952918
20.

Diet and risk of dementia: Does fat matter?: The Rotterdam Study.

Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, Breteler MM.

Neurology. 2002 Dec 24;59(12):1915-21.

PMID:
12499483

Supplemental Content

Support Center